Clinical Trial Update: Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, tolerability and efficacy of evolocumab in children with familial hypercholesterolemia; study completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2022-01-14